The business of producing psychedelics for science

by Aya Gonzalez

Jun 23, 2020

The Daily Hive’s Peter Smith speaks to Numinus CEO, Payton Nyquvest, about the business side of psychedelic-assisted therapy research and how Numinus’s amended Health Canada licence puts them in a unique position to advance the category.

Click here to read the full article.

We want to connect with you!

Sign up here so we can keep in touch.